yes I know but all things being equal we could see results of the asthma trial in the second half of the year. I suggest some of the restraint will be the effects/perceptions taken from the funding arrangements which could easily hamper share price short term. doesn't really bother me because I can still top up on any weakness and new holders are still buying at the low end of the price range right now.
IVX Price at posting:
5.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)